Two cases in our cohort demonstrated a discrepancy between AD markers (high Thal Aβ but low Braak NFT stages), consistent with an Aβ-predominant phenotype previously described within MSA [48]; both individuals carried the APOE-ε4 allele. Here, APOE is linked to Alzheimer disease.